Journal of the Korean Association of Oral and Maxillofacial Surgeons最新文献

{"title":"Management and treatment of four cases of oral carcinoma cuniculatum.","authors":"Constantinos Mourouzis, Iordanis Toursounidis, Christos Eftychiadis, Georgios Rallis","doi":"10.5125/jkaoms.2024.50.1.35","DOIUrl":"10.5125/jkaoms.2024.50.1.35","url":null,"abstract":"<p><strong>Objectives: </strong>Oral carcinoma cuniculatum (OCC) is a rare variant of squamous cell carcinoma (SCC). It has similar clinicopathological characteristics to SCC and verrucous carcinoma (VC). We present a case series of OCC and analyse its unique features, diagnosis, and management. Patients and.</p><p><strong>Methods: </strong>We retrospectively reviewed the medical records of oral cancer patients treated by Oral and Maxillofacial Surgery department from 2009 to 2020 with OCC biopsy findings. The clinicopathological characteristics and management of the OCC cases were analysed.</p><p><strong>Results: </strong>Four patients were identified with histologic findings of OCC, including three on the alveolar ridge mucosa and one on the tongue. Imaging revealed that two of the lesions located in the maxilla had osseous lysis. All four patients were all treated with radical excision, and the histopathology showed findings of SCC cuniculatum. It was decided that no further treatment was necessary. None of the patients has experienced recurrence during follow-up.</p><p><strong>Conclusion: </strong>OCC is a distinct entity that is more locally aggressive than VC but is associated with good prognosis. Radical surgical removal is considered appropriate for OCC. Emphasis should be given on an early diagnosis, as it remains challenging.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10909999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic and management challenge of concurrent tongue squamous cell carcinoma with an unknown parapharyngeal mass.","authors":"Raymond Shupak, Roderick Kim, Jun Hyuk Huh","doi":"10.5125/jkaoms.2024.50.1.56","DOIUrl":"10.5125/jkaoms.2024.50.1.56","url":null,"abstract":"<p><p>There are very few case reports of the diagnosis and management of concurrent oral cavity and parapharyngeal space tumors. We present a case involving a 49-year-old female who presented with oral cavity squamous cell carcinoma confirmed by biopsy. Initial diagnostic workup revealed a concurrent parapharyngeal mass. Diagnostic studies and surgical therapy were tailored to account for both pathological entities. The patient was treated with a combination of surgery and adjuvant therapy. The surgical strategy was designed to address both lesions simultaneously. One year post-surgery, the patient had good response to therapy with no evidence of persistent or recurrent disease. This report discusses the outcome and treatment of a rare case of concurrent squamous cell carcinoma with a complicating parapharyngeal space tumor. It explores the diagnostic process, comprehensive workup, and the surgical management.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Temporomandibular joint injection therapy.","authors":"Young-Kyun Kim","doi":"10.5125/jkaoms.2024.50.1.1","DOIUrl":"10.5125/jkaoms.2024.50.1.1","url":null,"abstract":"","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of the effects of two different styles of orally prescribing prednisolone on postoperative sequelae of surgical extraction of an impacted mandibular third molar: a single-blind randomized study.","authors":"Mohammed Mousa H Bakri, Faisal Hussain Alabdali, Rashed Hussain Mahzari, Thamer Jabril Rajhi, Norah Mohammed Gohal, Rehab Abdu Sufyani, Asma Ali Hezam, Ahtesham Ahmed Qurishi, Hamed Mousa Bakri, Fareedi Mukram Ali","doi":"10.5125/jkaoms.2024.50.1.27","DOIUrl":"10.5125/jkaoms.2024.50.1.27","url":null,"abstract":"<p><strong>Objectives: </strong>Surgical intervention for removal of an impacted third molar can lead to significant pain and swelling. Corticosteroids show promise for mitigating postoperative sequelae across various surgical contexts. The use of corticosteroids following minor oral surgery, though controversial, has already been proven effective. However, little research has explored peroral prescription of corticosteroids despite its convenience for outpatients and for non-surgeons like implantologists and periodontists and others who don't have access to needle injections. The aim of this study was to address a void in the literature by comparing the effects of two styles of preoral administration of prednisolone after surgical removal of the mandibular third molar and to determine which style minimizes postoperative sequelae.</p><p><strong>Materials and methods: </strong>A randomized, split-mouth clinical study was conducted to investigate the efficacy of two different styles of preoral prednisolone in mitigating postoperative sequelae following surgical extraction of impacted mandibular third molars. Fifteen participants were enrolled in the study. Random selection was used to determine the prescription style for the right and left mandibular arch. Group A included those who received a single dose of prednisolone 25 mg, while group B received prednisolone 5 mg postoperatively for a period of three days (5 mg three times/day on the first postoperative day, 5 mg twice/day on the second postoperative day; 5 mg once/day on the third postoperative day).</p><p><strong>Results: </strong>There was a significant difference in the distance between the corner of the mouth and tragus, which decreased with the time interval with respect to group B when compared to group A.</p><p><strong>Conclusion: </strong>The present study showed that a three-day tapered dose of prednisolone postoperatively was more effective in reducing post-extraction sequelae than a single-dose regimen.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Central giant-cell granuloma in a patient with neurofibromatosis type 1: 7 years of follow-up.","authors":"Michelle Briner Garrido, Rohan Jagtap, Christopher D Matesi, Vivian Diaz, John Hardeman, Anita Gohel","doi":"10.5125/jkaoms.2024.50.1.49","DOIUrl":"10.5125/jkaoms.2024.50.1.49","url":null,"abstract":"<p><p>Neurofibromatosis type 1 (NF1) is an autosomally dominant tumor suppressor syndrome and multisystem disease. Central giant-cell granulomas (CGCGs) can be seen in patients with NF1. A 21-year-old female was diagnosed with two CGCGs, one in the mandible and then one in the maxilla, in a 7-year period. Increased incidence of CGCGs in NF1 patients was thought to be caused by an underlying susceptibility to developing CGCG-like lesions in qualitatively abnormal bone, such as fibrous dysplasia. However, germline and somatic truncating second-hit mutations in the NF1 gene have been detected in NF1 patients with CGCGs, validating that they are NF1-associated lesions. Oral manifestations in patients with NF1 are very common. Knowledge of these manifestations and the genetic link between NF1 and CGCGs will enhance early detection and enable optimal patient care.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chyle leak after head and neck surgeries: a comprehensive review of diagnosis and management strategies.","authors":"Aparna Ganesan, Nehal C Singh, Naren P Khatri, Charanjeet Singh Madaan, Savreek Kaur, Amanjot Kaur","doi":"10.5125/jkaoms.2024.50.1.3","DOIUrl":"10.5125/jkaoms.2024.50.1.3","url":null,"abstract":"<p><p>Chyle leaks are uncommon complications after head and neck surgeries. Although uncommon, such a complication is noteworthy mention due to its perplexing diagnosis and management strategies. This scoping review aims to highlight and emphasize the diagnosis and management options proposed in the literature. A comprehensive search was performed in PubMed, Google Scholar, Cochrane Library, and Scopus databases and identified 617 articles that were reduced to 40 studies and reports after applying the eligibility criteria. Although numerous treatment options ranging from simple, conservative measures to invasive surgical procedures have been mentioned for low-output, high-output, and massive leaks, there is no concrete evidence on the best method. Thus, a combination of management options must be customized by case for optimum results.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comments regarding the paper \"Lesch-Nyhan syndrome: a case report\" published recently by Park et al. in <i>J Korean Assoc Oral Maxillofac Surg</i>.","authors":"Joseph Shapira","doi":"10.5125/jkaoms.2023.49.6.369","DOIUrl":"10.5125/jkaoms.2023.49.6.369","url":null,"abstract":"","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10761311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139059061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Xanthogranulomatous inflammation of the lower jaw bone: a rare case report.","authors":"Hyesung Bae, Kil-Hwa Yoo, Min-Seok Oh","doi":"10.5125/jkaoms.2023.49.6.360","DOIUrl":"10.5125/jkaoms.2023.49.6.360","url":null,"abstract":"<p><p>Xanthogranulomatous inflammation (XGI) is an uncommon type of chronic inflammation and is histologically characterized by foamy histiocytes and giant cells. The most common sites of occurrence are kidneys and gallbladder. The etiology remains controversial. Involvement of the lower jaw bone is rare. In this study, we report a case of XGI presenting in the lower jaw.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10761317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139059069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dental trauma trends in emergency care:a comparative analysis before, during, and after COVID-19.","authors":"Woo-Jung Yang, Ji-Young Yoon","doi":"10.5125/jkaoms.2023.49.6.339","DOIUrl":"10.5125/jkaoms.2023.49.6.339","url":null,"abstract":"<p><strong>Objectives: </strong>This analysis details the characteristics of dental trauma in South Korea during the coronavirus disease 2019 (COVID-19) (DC) pandemic and compares them in patients before and after COVID-19 (BC and AC, respectively).</p><p><strong>Materials and methods: </strong>Data were collected from medical records of patients who visited Seoul National University Bundang Hospital's Emergency Dental Care Center during three 12-month periods: BC, DC, and AC (BC from March 1, 2019 to February 29, 2020; DC from March 1, 2020 to February 28, 2021; AC from March 1, 2022 to February 28, 2023). A retrospective review was conducted to investigate patient age, sex, time of visit, cause, and diagnosis. The study included 1,544 patients: 660 BC, 374 DC, and 510 AC.</p><p><strong>Results: </strong>Significant difference in age and sex was not observed among the three periods; 1-9 years of age was the largest group (38.3% in BC, 29.6% in DC, and 27.8% in AC), and the percentage of male patients was greater than of female patients (male proportion as 63.5% in BC, 67.4% in DC, and 64.9% in AC). The number of patients generally peaked at a Saturday night in spring (for BC: May, Saturday, 18:00-19:59; for DC: March, Saturday, 18:00-19:59; for AC: April as the second most (October as the most peaked), Saturday, 20:00-21:59). The primary etiology of the dental trauma was identical in the three periods: falls, followed by sports. The most frequent diagnosis was laceration, followed by tooth avulsion and jaw fracture.</p><p><strong>Conclusion: </strong>Significant differences were not found between the characteristics and patterns of dental trauma in the BC, DC, and AC periods. However, due to the pandemic and social distancing, activities decreased and associated dental trauma-related incidents declined.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10761316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139059063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Review of two immunosuppressants: tacrolimus and cyclosporine.","authors":"HyunJong Lee, Hoon Myoung, Soung Min Kim","doi":"10.5125/jkaoms.2023.49.6.311","DOIUrl":"10.5125/jkaoms.2023.49.6.311","url":null,"abstract":"<p><p>Immunosuppressants are vital in organ transplantation including facial transplantation (FT) but are associated with persistent side effects. This review article was prepared to compare the two most used immunosuppressants, cyclosporine and tacrolimus, in terms of mechanism of action, efficacy, and safety and to assess recent trials to mitigate their side effects. PubMed and Google Scholar queries were conducted using combinations of the following search terms: \"transplantation immunosuppressant,\" \"cyclosporine,\" \"tacrolimus,\" \"calcineurin inhibitor (CNI),\" \"efficacy,\" \"safety,\" \"induction therapy,\" \"maintenance therapy,\" and \"conversion therapy.\" Both immunosuppressants inhibit calcineurin and effectively down-regulate cytokines. Tacrolimus may be more advantageous since it lowers the likelihood of acute rejection, has the ability to reverse allograft rejection following cyclosporine treatment, and has the potential to reinnervate nerves. Meanwhile, graft survival rates seem to be comparable for the CNIs. To avoid nephrotoxicity, various immunosuppressants other than CNIs have been studied. Despite averting nephrotoxicity, these medications show increases in acute rejection or other types of adverse effects compared to CNIs. FT has been a topic of interest for oral and maxillofacial surgeons, and the postoperative usage of immunosuppressants is crucial for the long-term prognosis of FT. As contemporary transplantation regimens incorporate novel medications along with CNIs, further research is required.</p>","PeriodicalId":51711,"journal":{"name":"Journal of the Korean Association of Oral and Maxillofacial Surgeons","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10761313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139059066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}